AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

BIO-TECHNE Corp Director's Dealing 2011

Aug 1, 2011

30718_dirs_2011-08-01_43d3dcf7-5f06-45ef-b4e6-375a226b7330.zip

Director's Dealing

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: TECHNE CORP /MN/ (TECH)
CIK: 0000842023
Period of Report: 2011-07-28

Reporting Person: MELSEN GREGORY J (VP Finance and CFO)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2011-07-28	Stock Option	$76.15	A	1803	Acquired	2018-07-27	Common Stock (1803)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	582	Indirect

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option	$58.4	2017-07-29	Common Stock (2083)	2083	Direct
Stock Option	$66.25	2017-04-29	Common Stock (30000)	30000	Direct
Stock Option	$62.46	2016-07-23	Common Stock (203)	203	Direct
Stock Option	$79.41	2015-07-24	Common Stock (596)	596	Direct
Stock Option	$56.83	2014-07-26	Common Stock (783)	783	Direct
Stock Option	$49.43	2013-07-26	Common Stock (1012)	1012	Direct
Stock Option	$51.6	2012-08-17	Common Stock (426)	426	Direct
Stock Option	$39.53	2014-12-16	Common Stock (25000)	25000	Direct

Footnotes

F1: Vest 7500 each 4/30/11, 4/30/12, 4/30/13, 4/30/14